Rady Children's Institute for Genomic Medicine Partners With Inozyme Pharma on NGS Newborn Screening

Rady has begun a pilot program to evaluate WGS-based screening for approximately 400 rare genetic diseases as a supplement to existing newborn screening.

Related Keywords

,Inozyme Pharma ,Stephen Kingsmore ,Catherine Nester ,Astrazeneca ,Rady Children Institute For Genomic Medicine ,Rady Children ,Genomic Medicine ,Fabric Genomics ,Travere Therapeutics ,